ClinicalTrials.gg
Sign In

Drug

HRS-7058 clinical trials

Also written HRS-7058.

studies test it
4
open now
4
in phase 3
1
first study started
2025

Keep track of what changes. Save the HRS-7058 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

HRS-7058
4

Studies by the year they started

4 studies that test it; most in 2026 (3)

Studies that test HRS-7058, by start year
YearStudies
20251
20263

By phase

A phase 1/2 study counts in both.

Phase 2
3
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Pancreatic Neoplasms
1

Who runs them

Industry 3 · Other 1

Shandong Suncadia Medicine Co., Ltd. (3) · Fudan University (1)

Often tested with

Tested in the same studies.

SHR-1701 (1) · Anti-CTLA-4 Monoclonal Antibody SHR-8068 (1) · Xelox (1) · KRAS G12D Inhibitor HRS-4642 (1)

Studies

Open first, then newest update. How each study uses HRS-7058 is read from its arms, and is right about nine times in ten.

Testing it · 4